comparemela.com
Home
Live Updates
Icosavax Reports Third Quarter Financial Results and : comparemela.com
Icosavax Reports Third Quarter Financial Results and
- Initiated a Phase 1 trial of Icosavax’s first combination bivalent vaccine candidate, IVX-A12, against respiratory syncytial virus (RSV) and human...
Related Keywords
United States ,
Jessica Yingling ,
Tachi Yamada ,
Laurence Watts ,
Adam Simpson ,
Institute For Protein Design ,
Little Dog Communications Inc ,
Nasdaq ,
Exchange Commission ,
Icosavax Inc ,
University Of Washington ,
Gilmartin Group ,
Chief Executive Officer ,
Subsequent Highlights ,
Protein Design ,
Private Securities Litigation Reform Act ,
Nasdaq Icvx ,
Icosavax ,
Nc ,
comparemela.com © 2020. All Rights Reserved.